Cargando…
Low-dose, long-term macrolide therapy in asthma: An overview
Macrolides, a class of antimicrobials isolated from Streptomycetes more than 50 years ago, are used extensively to treat sinopulmonary infections in humans. In addition, a growing body of experimental and clinical evidence indicates that long-term (years), low (sub-antimicrobial)-dose 14- and 15-mem...
Autores principales: | Hatipoğlu, Umur, Rubinstein, Israel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC394343/ https://www.ncbi.nlm.nih.gov/pubmed/15023231 http://dx.doi.org/10.1186/1476-7961-2-4 |
Ejemplares similares
-
Effects of long-term macrolide therapy at low doses in stable COPD
por: Cao, Yueqin, et al.
Publicado: (2019) -
The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
por: Ryu, Gwanghui, et al.
Publicado: (2023) -
Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases
por: Sun, Jialiang, et al.
Publicado: (2021) -
Long-term macrolides in diffuse interstitial lung diseases
por: Faverio, Paola, et al.
Publicado: (2017) -
Atypical Bacteria and Macrolides in Asthma
por: Xepapadaki, Paraskevi, et al.
Publicado: (2008)